Becton Dickinson (BDX) Tops Q1 EPS by 30c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
BD Reports First Quarter Fiscal 2023 Financial Results
February 2, 2023 6:30 AM ESTExecution of BD 2025 Strategy Delivering Consistent and Durable Performance
Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basisRevenue from base business (which excludes COVID-only diagnostic testing) grew 0.4% as reported, 5.2% currency-neutralGAAP and adjusted diluted EPS from continuing operations of $1.70 and $2.98, respectivelyCompany raises full-year revenue and adjusted EPS guidanceFRANKLIN LAKES, N.J., Feb. 2, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal 2023, which ended December 31, 2022.
... More